EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human Vγ9Vδ2 T cells exhibit antifungal activity against Aspergillus fumigatus and other filamentous fungi

Satoru Koga iD, Takahiro Takazono iD, Hodaka Namie, Daisuke Okuno, Yuya Ito, Nana Nakada, Tatsuro Hirayama iD, Kazuaki Takeda, Shotaro Ide, Naoki Iwanaga, Masato Tashiro iD, Noriho Sakamoto und 5 weitere

Microbiology Spectrum · 02.04.2024 · 12 (4)

DOI: 10.1128/spectrum.03614-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.04.2024. Verfasst von Satoru Koga und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. Hauptthemen laut MEDLINE: Mucormycosis, Aspergillosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), MEXT | Japan Society for the Promotion of Science (JSPS), Ministry of Education, Culture, Sports, Science and Technology (MEXT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive aspergillosis (IA) and mucormycosis are life-threatening diseases, especially among immunocompromised patients. Drug-resistant Aspergillus fumigatus strains have been isolated worldwide, which can pose a serious clinical problem. As IA mainly occurs in patients with compromised immune systems, the ideal therapeutic approach should aim to bolster the immune system. In this study, we focused on Vγ9Vδ2 T cells that exhibit immune effector functions and examined the possibility of harnessing this unconventional T cell subset as a novel therapeutic modality for IA. A potent antifungal effect was observed when A. fumigatus ( Af293 ) hyphae were challenged by Vγ9Vδ2 T cells derived from peripheral blood. In addition, Vγ9Vδ2 T cells exhibited antifungal activity against hyphae of all Aspergillus spp., Cunninghamella bertholletiae , and Rhizopus microsporus but not against their conidia. Furthermore, Vγ9Vδ2 T cells also exhibited antifungal activity against azole-resistant A. fumigatus , indicating that Vγ9Vδ2 T cells could be used for treating drug-resistant A. fumigatus . The antifungal activity of Vγ9Vδ2 T cells depended on cell-to-cell contact with A. fumigatus hyphae, and degranulation characterized by CD107a mobilization seems essential for this activity against A. fumigatus . Vγ9Vδ2 T cells could be developed as a novel modality for treating IA or mucormycosis. IMPORTANCE Invasive aspergillosis (IA) and mucormycosis are often resistant to treatment with conventional antifungal agents and have a high mortality rate. Additionally, effective antifungal treatment is hindered by drug toxicity, given that both fungal and human cells are eukaryotic, and antifungal agents are also likely to act on human cells, resulting in adverse effects. Therefore, the development of novel therapeutic agents specifically targeting fungi is challenging. This study demonstrated the antifungal activity of Vγ9Vδ2 T cells against various Aspergillus spp. and several Mucorales in vitro and discussed the mechanism underlying their antifungal activity. We indicate that adoptive immunotherapy using Vγ9Vδ2 T cells may offer a new therapeutic approach to IA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucormycosisAspergillosisHumansAntifungal AgentsAspergillus fumigatusFungiAspergillus

Stichwörter der Autor:innen

filamentous fungiinvasive aspergillosisnitrogen-containing bisphosphonate prodrugγδ T cell

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
  • Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Health Center, Nagasaki University, Nagasaki, Japan.
  • Department of Pharmacotherapeutics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Infectious Diseases Experts Training Center, Nagasaki University Hospital, Nagasaki, Japan.

ORCID-Profile: Satoru Koga, Takahiro Takazono, Tatsuro Hirayama, Masato Tashiro, Akira Watanabe

Förderung

  • Japan Agency for Medical Research and Development (AMED)
  • MEXT | Japan Society for the Promotion of Science (JSPS)
  • Ministry of Education, Culture, Sports, Science and Technology (MEXT)
  • Nagasaki University

Zitieren

APA

Koga, S., Takazono, T., Namie, H., Okuno, D., Ito, Y., Nakada, N., Hirayama, T., Takeda, K., Ide, S., Iwanaga, N., Tashiro, M., Sakamoto, N., Watanabe, A., Izumikawa, K., Yanagihara, K., Tanaka, Y., & Mukae, H. (2024). Human Vγ9Vδ2 T cells exhibit antifungal activity against Aspergillus fumigatus and other filamentous fungi. Microbiology Spectrum, 12(4). https://doi.org/10.1128/spectrum.03614-23

Vancouver

Koga S, Takazono T, Namie H, Okuno D, Ito Y, Nakada N, et al. Human Vγ9Vδ2 T cells exhibit antifungal activity against Aspergillus fumigatus and other filamentous fungi. Microbiology Spectrum. 2024;12(4). doi:10.1128/spectrum.03614-23

BibTeX
@article{Koga2024,
  author = {Koga, Satoru and Takazono, Takahiro and Namie, Hodaka and Okuno, Daisuke and Ito, Yuya and Nakada, Nana and Hirayama, Tatsuro and Takeda, Kazuaki and Ide, Shotaro and Iwanaga, Naoki and Tashiro, Masato and Sakamoto, Noriho and Watanabe, Akira and Izumikawa, Koichi and Yanagihara, Katsunori and Tanaka, Yoshimasa and Mukae, Hiroshi},
  title = {Human Vγ9Vδ2 T cells exhibit antifungal activity against Aspergillus fumigatus and other filamentous fungi},
  journal = {Microbiology Spectrum},
  year = {2024},
  volume = {12},
  number = {4},
  doi = {10.1128/spectrum.03614-23}
}
Kostenlos starten →